QUANTUM X LABS INC. QXL
Inc. (the "Registrant", "Viewbix" or the "Company") was incorporated in the State of Delaware on
August 16, 1985, under a predecessor name, The InFerGene Company ("InFerGene Company"). On August 25, 1995, a wholly owned
subsidiary of InFerGene Company merged with Zaxis International, Inc., an Ohio corporation, which following such merger, the surviving
entity, InFerGene Company, changed its name to Zaxis International, Inc. ("Zaxis"). Our principal executive offices are located
Last close
3.62
2026-10-23
Market cap
$78.1M
2026-06-30 share count
52-week range
2.97 - 7.70
Valuation FY2025 figures against the last close
P/S—
P/E1.6x
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS2.28
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $26.9M | $79.6M | $96.6M | $45.2M | $38.1M | $208.0K | $252.0K | — | — |
| Cost of revenue | — | — | — | — | — | $5.0K | $2.0K | $75.0K | — | — |
| Gross profit | — | — | — | — | $41.0K | $91.0K | $206.0K | $177.0K | — | — |
| R&D | $69.0K | $830.0K | $2.9M | $3.3M | $2.4M | $2.7M | $233.0K | $258.0K | -$354.8K | -$1.6M |
| SG&A | $1.6M | $1.9M | $2.9M | $2.2M | $1.4M | $1.7M | $720.0K | $317.0K | $557.3K | -$3.7M |
| Total operating expenses | — | — | — | — | $395.0K | $545.0K | $1.2M | $755.0K | -$557.3K | -$5.4M |
| Operating income | -$2.2M | -$837.0K | -$7.5M | $2.7M | $541.0K | $2.0M | -$1.0M | -$578.0K | -$557.3K | -$5.4M |
| Interest expense | $63.0K | $160.0K | $87.0K | $143.0K | — | — | — | — | — | — |
| Pre-tax income | -$13.4M | -$3.4M | -$8.8M | $1.3M | $681.0K | $2.5M | -$1.1M | -$560.0K | — | — |
| Income tax | $39.0K | $131.0K | $66.0K | $153.0K | $90.0K | $181.0K | $15.0K | $15.0K | — | — |
| Net income | -$19.3M | -$12.1M | -$7.3M | $28.0K | $300.0K | $2.3M | -$1.1M | -$575.0K | -$1.5M | -$6.1M |
| EPS, basic | 2.28 | 2.69 | 1.97 | 0.00 | 0.02 | 0.16 | — | — | — | — |
| EPS, diluted | 2.28 | 2.69 | 1.97 | 0.00 | 0.02 | 0.16 | -0.08 | -2.11 | -0.07 | -0.32 |
| Shares, diluted (wtd. avg.) | 8.5M | 4.5M | 3.7M | 15.0M | 15.0M | 15.0M | — | — | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $1.0M | $24.0K | $1.8M | $4.2M | $5.2M | $148.0K | $87.0K | $51.0K | $3.0K | $4.5K |
| Short-term investments | — | — | — | — | — | — | — | $17.2K | — | — |
| Receivables | $315.0K | $557.0K | $11.4M | $20.9M | $16.4M | $15.0K | — | $15.0K | — | — |
| Total current assets | $1.7M | $7.8M | $17.8M | $29.8M | $29.2M | $225.0K | $225.0K | $153.0K | $15.2K | $13.8K |
| Property, plant and equipment | $56.0K | $17.0K | $245.0K | $302.0K | $334.0K | — | $5.0K | $5.0K | $14.3K | $31.8K |
| Goodwill | $6.4M | $1.1M | $12.3M | $17.4M | $12.5M | — | — | — | — | — |
| Other intangibles | $2.0M | $1.9M | $4.9M | $35.1M | $8.4M | — | — | — | — | — |
| Total assets | $10.8M | $22.0M | $43.3M | $63.7M | $51.3M | $225.0K | $230.0K | $158.0K | $29.5K | $57.6K |
| Accounts payable | $1.2M | $2.4M | $12.4M | $19.8M | $16.7M | — | — | $13.1K | $123.7K | $198.8K |
| Short-term debt | $781.0K | $3.1M | $1.4M | $1.5M | $5.1M | $50.0K | — | — | — | — |
| Total current liabilities | $4.1M | $12.9M | $19.8M | $28.5M | $26.8M | $2.3M | $1.9M | $833.0K | $1.0M | $1.3M |
| Long-term debt | $586.0K | $496.0K | $3.1M | $2.9M | $4.3M | — | — | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | $975.2K | $1.6M | $1.3M |
| Retained earnings | -$46.0M | -$22.7M | -$10.7M | -$3.3M | -$2.4M | -$15.2M | -$14.7M | -$13.6M | -$16.6M | -$15.0M |
| Total equity | $5.0M | $5.8M | $18.6M | $29.9M | $18.5M | $13.3M | -$1.7M | -$721.0K | -$395.0K | -$1.2M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$2.8M | $1.4M | $934.0K | $3.2M | $4.4M | $3.0M | -$135.0K | $30.0K | -$630.0K | -$858.5K |
| Depreciation and amortisation | $67.0K | $115.0K | $73.0K | $90.0K | $94.0K | $1.7M | $1.0K | $2.0K | $17.5K | $12.4K |
| Stock-based compensation | $75.0K | $69.0K | $135.0K | $71.0K | -$43.0K | $103.0K | — | — | $76.6K | $2.0M |
| Capital expenditure | — | $1.0K | $16.0K | $58.0K | $311.0K | $55.0K | $2.0K | — | — | $23.1K |
| Investing cash flow | -$151.0K | -$1.0K | -$16.0K | -$74.0K | -$10.8M | -$222.0K | -$1.0K | — | $11.9K | -$35.0K |
| Financing cash flow | $3.8M | -$2.1M | -$3.4M | -$4.2M | $8.3M | -$1.3M | $174.0K | $2.0M | $606.3K | $782.6K |
| Dividends paid | — | — | $130.0K | $73.0K | — | $386.0K | — | — | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-013205.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $252.0K | $208.0K | $38.1M | $45.2M | $96.6M | $79.6M | $26.9M | — |
| Gross profit | — | — | $177.0K | $206.0K | $91.0K | $41.0K | — | — | — | — |
| Net income | -$6.1M | -$1.5M | -$575.0K | -$1.1M | $2.3M | $300.0K | $28.0K | -$7.3M | -$12.1M | -$19.3M |
Recent filings and events
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Other event Item 8.01
- Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Other event Item 8.01
- Regulation FD disclosure Item 7.01
- Other event Item 8.01
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
- Material agreement signed Item 1.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 7372
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| MSFT | MICROSOFT CORP | $3.89T | 29.2x | 17.8% |
| PLTR | Palantir Technologies Inc. | $472.16B | 312.3x | 56.2% |
| ORCL | ORACLE CORP | $363.40B | 21.6x | 17.3% |
| CRWD | CrowdStrike Holdings, Inc. | $263.73B | — | 21.7% |
| SHOP | SHOPIFY INC. | $218.48B | 179.4x | 30.1% |
| CRM | Salesforce, Inc. | $204.57B | 31.9x | 9.6% |
| NOW | ServiceNow, Inc. | $164.36B | 95.2x | 20.9% |
| NET | Cloudflare, Inc. | $115.42B | — | 29.8% |